Once internalized, these dipeptide species activate amino-acid signalling via a pathway involving p38MAPK and the stemness transcription factor Smad3, which promotes CML stem cell maintenance. This evidence concerns the gene SMAD3 and chronic myelogenous leukemia, BCR-ABL1 positive.